Health exam shows small nodule on Biden's prostate. Now what?
Former President Joe Biden was hospitalized overnight last Friday in Philadelphia for 'further evaluation' of a small nodule found on his prostate during a physical exam.
Biden's spokesman told The New York Times he would not be providing any additional information about the former president's care. But prostate issues are not uncommon in older men.
Biden is 82 and was the oldest serving president when he left office in January.
A number of issues can be found in older prostates, including benign prostatic hyperplasia (called simply BPH and very common), prostatitis and prostate cancer. The National Institute on Aging explains that the prostate is a small gland that helps men make semen. It wraps around the tube that carries both semen and urine from the body and the prostate naturally tends to enlarge as men age.
BPH requires 'watchful waiting' to see if symptoms such as urination frequency and pain or lower back and groin area pain and stiffness get worse. Medication can also be given to shrink the prostate or provide pain relief by relaxing the muscles. Other, less common approaches include surgery or use of radio waves or lasers.
Acute bacterial prostatitis usually starts with a bacterial infection, so the institute recommends men visit their doctor if the symptoms of prostate trouble are accompanied by fever, chills or pain. It's typically treated with antibiotics.
There are two other degrees of prostatitis — the 'itis' part in medicine means inflammation — including chronic bacterial infection and 'chronic prostatitis,' which is chronic pelvic pain syndrome. That, like the treatments for BPH, can require medicine, surgery or lifestyle changes to provide relief.
After screening tests including a digital exam and blood work, a person with a nodule or enlarged prostate may be referred to a urologist for a biopsy, which takes small tissue samples to look for cancer.
Even if cancer is detected, treatment may be watchful waiting because prostate cancer is often, though not always, slow-moving. Other treatment options include surgery, radiation therapy and hormone therapy or a combination.
The concern on everyone's mind is, of course, prostate cancer, which is relatively common for older American men. Risk goes up with age after 50, family history, regularly consuming a high-fat diet and race, as prostate cancer is most common in Black men, followed by white, Hispanic and Native American men. Asian American men have the lowest risk.
ABC News reported it's not the first brush with potential cancer for Biden. 'In February 2023 during his presidency, Biden had a lesion removed from his chest that was cancerous and, before entering office, Biden had several non-melanoma skin cancers removed with Mohs surgery.'
Mohs is a tissue-sparing procedure that takes cancerous tissue but as little noncancerous tissue as possible by checking tissue margins for cancer cells.
Basal cell carcinoma, which is the type of cancer he had, does not typically 'spread' to other parts of the body.
Prostate cancer is the most common cancer for men in the U.S., aside from non-melanoma skin cancer, impacting nearly 115 men per 100,000, according to the Centers for Disease Control and Prevention. That's more than twice as many as the number of men who get lung and bronchus cancer, colon and rectum cancer or urinary bladder cancer, which are the next most common.
In 2021, close to 237,000 new cases of prostate cancer were diagnosed.
While most older men who do have prostate cancer die with the disease, rather than of it, prostate cancer can kill. It is one of the leading causes of cancer deaths for men, behind lung and bronchus cancer. In 2022, 33,363 men died of prostate cancer in the U.S., per the CDC.
According to Newsweek, Biden was declared 'fit to serve' in February 2024 after a physical at Walter Reed National Military Medical Center.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Anti-DEI group targets Geisinger College of Health Sciences over program
SCRANTON — A national anti-DEI group has targeted the Geisinger College of Health Sciences with recent filings of discrimination complaints. Virginia-based Do No Harm purported in news releases in March and June that it filed separate complaints with two federal agencies against the college, citing as discriminatory its federally funded Center of Excellence for Diversity and Inclusion and a summer program that aimed to help students from Black, Hispanic or Native American communities that are underrepresented in the medical field transition into medical school. The Do No Harm discrimination complaints come amid President Donald Trump's efforts to dismantle DEI, or diversity, equity and inclusion, programs in the public and private sectors. Trump issued executive orders in the first week of his second term targeting DEI initiatives. 'Geisinger College of Health Sciences did a thorough review of our programs after the presidential executive orders were issued to ensure compliance. The pre-matriculation program referenced in the (Do No Harm) complaint ended in 2024 and is no longer active,' Geisinger CHS said in a statement. Do No Harm is labeled by the Southern Poverty Law Center as an 'anti-LGBTQ+ hate group.' Critics of the SPLC say it's politically biased and its definition of hate group is overly broad. Do No Harm first filed a complaint with the U.S. Department of Health and Human Services on March 19 against Geisinger CHS, according to a news release posted on the Do No Harm website. A member of Do No Harm then filed a similar complaint June 5 with the U.S. Department of Education, because Geisinger 'did not learn its lesson' from the initial complaint filed with HHS, the advocacy organization announced in another news release. The Times-Tribune could not verify that the complaints were filed with both departments, and whether either agency investigated the allegations or took any actions. The U.S. Department of Health and Human Services and the U.S. Department of Education through separate representatives said they do not confirm the existence of complaints. Do No Harm, established in April 2022, claims it has 17,000 members, including doctors, nurses, physicians and concerned citizens, and cites its mission as safeguarding health care from ideological threats. 'Do No Harm seeks to highlight and counteract divisive trends in medicine, such as 'Diversity, Equity and Inclusion' and youth-focused gender ideology,' the organization's website says. According to the SPLC, Do No Harm in 2024 filed eight lawsuits challenging programs such as scholarships and fellowships for marginalized people. 'The group claims that the practice of nonprofit organizations like the American Association of University Women to provide fellowships to students of color and LGBTQ+ students — groups historically underrepresented in academia and medicine — harms patients by requiring medical schools to accept or fund unqualified candidates. According to the group, the case was dismissed 'after AAUW agreed to drop the racial criteria in the fellowship's selection process,'' the SPLC website says. According to the website of Geisinger College of Health Sciences, it is the research and education arm of the Geisinger health system. Established in 2022, the college unifies the Geisinger Commonwealth School of Medicine, Geisinger School of Nursing, Geisinger School of Graduate Education, graduate medical education, Center for Faculty and Professional Development and more. * Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER) * Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER) * Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER) Show Caption 1 of 3 Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER) Expand
Yahoo
35 minutes ago
- Yahoo
Ants With Potentially Fatal Sting Spotted in 20 U.S. States
Americans should be on alert for a stinging insect that's spreading across the United States this June. So far, at least 20 states have detected Asian needle ants. They've been found mostly in the northeastern and southeastern regions of the United States. However, some were spotted in Texas, Washington and Wisconsin. Asian needle ants were first discovered in the United States in 1932. The U.S. Forest Service said it takes "an experienced eye" to positively identify them. Dan Suiter, a professor for the University of Georgia College of Agricultural and Environmental Sciences, spoke to ABC News about this invasive species. He has received calls from three separate people who suffered anaphylaxis after getting stung by an Asian needle ant. "In 25 years, I've had one phone call from an individual who was stung by a fire ant and suffered anaphylaxis, another one by something called a twig ant," Suiter told ABC News. "When I start getting calls annually about people who have been stung by an Asian needle ant, it says to me that there's a trend there." If you're stung by an Asian needle ant you could also develop symptoms such as hives and itching, low blood pressure, swollen tongue or throat, nausea, dizziness, weak or rapid pulse, and difficulty breathing. Asian needle ants usually nest themselves in dark, hidden hardwood habitats. Their population typically grows during the warmer weather months. Suiter is recommending that people remove nesting sites of hardwood. That's if they're going to be working outside this summer. Ants With Potentially Fatal Sting Spotted in 20 U.S. States first appeared on Men's Journal on Jun 10, 2025
Yahoo
35 minutes ago
- Yahoo
There's one vice RFK Jr. isn't talking about
Robert F. Kennedy Jr. has made it his mission to remind Americans that they need to get off the couch and lay off the junk food. But there's one vice he's not talking about: smoking. That's troubled anti-smoking activists, researchers who focus on the diseases tobacco causes and Democrats in Congress who point out that smoking, despite a marked decline in recent years, still leads to more preventable deaths than anything else. Even so, Kennedy didn't mention the health impacts of smoking once in last month's Make America Healthy Again report assessing the biggest threats to Americans' health. That marks a turning point from the priorities of public health officials going back decades, including the Biden administration's, which targeted smoking as part of a moonshot plan to halve cancer death rates. Anti-tobacco advocates fear deemphasizing the dangers of tobacco could slow or even halt progress in driving down smoking rates. 'Attempting to combat chronic disease without tobacco control is like attempting a triathlon without a bicycle,' said Brian King, whom Kennedy pushed out of his job as the Food and Drug Administration's top tobacco regulator in April. 'You're destined for failure before leaving the starting line.' Since President Donald Trump's inauguration, his health agencies appear to have shelved two moves King planned to combat smoking: banning the last remaining legal cigarette flavoring, menthol, and requiring companies to reduce the amount of nicotine in their products. Nicotine is what makes cigarettes addictive. But an HHS spokesperson said the department 'remains steadfast in its mission to protect and promote public health,' adding that the MAHA report is not an 'exhaustive inventory of every HHS program or public health challenge.' 'HHS agencies continue to carry out their responsibilities, including work on tobacco control, with the highest level of integrity and commitment to the American public,' the spokesperson said. A sustained public health campaign to educate Americans about smoking's risks over decades has driven a huge decrease in use. In the 1960s, more than 4 in 10 adults smoked cigarettes. Now it's fewer than 1 in 8. And the public health success among kids is even starker. Fewer than 1 in 26 now smoke cigarettes, according to an analysis of federal data. The negative health impacts of tobacco use are well-studied and vast. For years it has been the top preventable cause of death in the United States, contributing to cancer, heart disease and stroke. But when Sen. Dick Durbin (D-Ill.) quizzed Kennedy about that during a budget hearing last month, asking him to name the 'No. 1 cause of preventable death in America today,' Kennedy was stumped. 'I'm not sure what you're talking about,' he said. Kennedy's apparent lack of interest in combating smoking — the word 'tobacco' appears in the MAHA report only within the context of his concerns about food marketing while 'smoking' and 'cigarettes' are never mentioned — also suggests this Trump administration won't be like the first. Then, Trump's FDA commissioner, Scott Gottlieb, put the menthol ban and the limits on nicotine on the table, drawing applause from anti-smoking activists. Congress permitted the agency to make those moves in a 2009 law. That law banned flavorings except menthol — which is a cash cow for Marlboro cigarette maker Philip Morris, whose support helped get the law passed — but gave the FDA the power to decide whether to ban it. It also gave the agency the power to force cigarette companies to reduce nicotine levels. The Obama administration didn't do so. President Joe Biden proposed limiting nicotine levels after the 2024 election but never finalized the rule. A Biden plan to ban menthol cigarettes in 2022 was also not finalized. Menthol is popular among Black smokers, and some Democrats feared a ban could alienate crucial voters in a presidential election year. Jerome Adams, who was surgeon general during the first Trump term, said he wants Kennedy to prioritize the tobacco regulations laid out in Gottlieb's tobacco regulation plan — an effort he said would benefit youth and marginalized communities that are disproportionately impacted by menthol cigarettes. 'These proposed regulations align with the MAHA movement's focus on preventing chronic diseases,' Adams said. The tobacco industry spent heavily on Trump's 2024 campaign — and already has a lot to show for it. Trump pledged to 'save' vaping on his social media site, Truth Social, in September after meeting with Vapor Technology Association Executive Director Tony Abboud. The Trump administration pushed King — whom the tobacco industry had criticized for years — out of his job leading the FDA's Center for Tobacco Products. Job dismissals led by Trump's Department of Government Efficiency also gutted the CDC Office on Smoking and Health, which oversees federal smoking cessation programs and studies. The Trump administration also slashed funds the National Institutes of Health disburses to research facilities, which scientists say could imperil tobacco smoking studies. Asked about the industry's contributions to the Trump campaign, White House spokesperson Kush Desai wrote in an email, 'the only special interest guiding the Administration's decision-making is the best interest of the American people.' Tobacco-control advocates say Trump's early moves could undermine the country's progress diminishing smoking and the diseases it causes. 'These levels are decreasing because we have made such a commitment over the past few decades to enact things to work to get these levels down,' said Catharine Young, a Biden administration official who worked on his cancer moonshot initiative. 'But if you stop that or if you don't increase that effort, they're not going to continue to go down. They're either going to flat line, or they're going to start rising again.' Both Democratic and Republican administrations have hesitated to use all the regulatory authorities the 2009 law granted them. After Gottlieb resigned in March 2019, the agency's efforts to advance his 2017 tobacco plan were snuffed out. 'With his resignation, we lost the champion for the 2017 plan, and some months after he resigned, I was literally ordered by political appointees at FDA to stop talking publicly about menthol and nicotine,' said Mitch Zeller, who led the FDA's Center for Tobacco Products before King. Ultimately, Zeller wasn't able to implement a menthol ban or nicotine limits during any of the three administrations he served. During Biden's administration, then-FDA Commissioner Robert Califf enlisted allies outside the government to lobby the White House after agency efforts to ban menthol cigarettes were held up at the Office of Management and Budget. But the final rule was not published before Biden left office. 'They caved to political pressure from cigarette companies,' Zeller said. The FDA estimated the plan to limit nicotine levels in cigarettes proposed during the Biden administration would avert 4.3 million deaths and prevent 48 million youth and young adults from starting habitual cigarette smoking by the end of the century if implemented. And banning menthol cigarettes in the U.S. would cut 324,000 to 654,000 smoking-attributable deaths by 2060, according to modeling studies cited in the 2022 proposal. Luis Pinto, a spokesperson for Reynolds American, the maker of Lucky Strike, Camel and Newport cigarettes, said the company has not yet met with Trump's FDA commissioner, Marty Makary. Pinto said the company is opposed to a menthol cigarette ban because it believes there are "more effective and sustainable ways to help adult smokers transition away from combustible cigarettes." 'Rather than setting a nicotine standard, the focus should be on expanding access to a diverse and innovative portfolio of potentially reduced-risk products,' Pinto said. 'Tobacco harm reduction, not prohibition, is the most effective path forward in reducing the health impacts of smoking.' On Capitol Hill, Kennedy has rarely discussed tobacco despite his focus on preventing chronic disease, disappointing lawmakers like Durbin, the second ranking Democrat in the Senate. In an interview with POLITICO, Durbin emphasized the tobacco industry is still a threat to public health, especially as it markets more novel forms of nicotine exposure like vaping, which has become popular among younger Americans. 'The tobacco companies have not given up. Their basic approach is to addict children to their product, and so now they're using vaping and [other] devices to get … high schoolers in America addicted to forms of nicotine,' Durbin said, referring to Gottlieb as a hero. 'I just don't think you can credibly say you're addressing public health in America and ignore tobacco and vaping.' King, who's now with the Campaign for Tobacco-Free Kids, an anti-smoking group, is still hoping to convince Trump officials that going after tobacco needs to be part of the MAHA agenda. And he says he sees hope in the FDA's crackdown on illegal e-cigarettes, which he interprets as a sign the government is looking to snuff out unapproved vaping products. 'We have seen the decimation of tobacco control infrastructure,' King said. 'It's important you have the resources and the people.'
